MRK - Geron surges after FDA AdCom backing for lead drug
2024-03-15 10:06:29 ET
More on Geron
- Geron: Advisory Nod Boosts Approval Odds, But Market Position Remains Hazy
- Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA
- Geron Corporation (GERN) Q4 2023 Earnings Call Transcript
- Geron wins FDA AdCom backing for blood cancer drug
- Geron slips as FDA reviews blood cancer therapy ahead of AdCom meeting